Targovax ASA logo

TRVX - Targovax ASA News Story

NOK8.05 0.4  4.6%

Last Trade - 3:25pm

Sector
Healthcare
Size
Micro Cap
Market Cap £49.3m
Enterprise Value £46.2m
Revenue £238k
Position in Universe 989th / 1784

BRIEF-Targovax: ONCOS-102 Passes Safety Reviews

Mon 11th December, 2017 6:00am
Dec 11 (Reuters) - TARGOVAX ASA  TRVX.OL : 
    * REG-TARGOVAX ANNOUNCES THAT FIRST COMBINATION TRIALS WITH 
ONCOS-102 HAVE PASSED THEIR INITIAL, PLANNED, INDEPENDENT SAFETY 
REVIEWS 
    * ONCOS-102 HAS BEEN WELL-TOLERATED IN COMBINATION WITH 
EITHER 
CHECKPOINT INHIBITOR OR CHEMOTHERAPY  
 
Source text for Eikon:  ID:nGNEbtFw5k  
Further company coverage:  TRVX.OL  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 587720920;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.